Target intelligence / Profile preview

Microbial cell wall and cell membrane

Molecular classification
Structural component, Biological barrier, Macromolecular complex
01

Overview

The microbial cell envelope, encompassing both the cell wall and the cell membrane, represents a fundamental structural complex essential for the survival and pathogenesis of bacteria and fungi (NIH, 2022). The bacterial cell wall is primarily composed of a cross-linked peptidoglycan polymer that maintains cellular shape and protects against osmotic lysis, while the fungal cell wall utilizes chitin and beta-glucans for similar purposes (StatPearls, 2023; PubMed, 2021). Beneath the wall, the cell membrane serves as a semi-permeable lipid bilayer that facilitates critical processes such as nutrient uptake, waste secretion, and signal transduction (Nature Reviews Microbiology, 2019). These structures are highly effective therapeutic targets because they contain components, such as peptidoglycan and ergosterol, that are absent in human cells, allowing for high selective toxicity (PubChem, 2024). Clinically, antibiotics like penicillins and glycopeptides target cell wall synthesis, whereas polymyxins and polyenes directly compromise membrane integrity to induce cell death (WHO, 2023). However, the broad nature of this target category reflects a diverse array of molecular sites, and the clinical utility of drugs hitting these sites is increasingly challenged by the global rise of antimicrobial resistance (CDC, 2022).

Other names
Microbial cell envelopeBacterial cell wallFungal cell wallCytoplasmic membranePeptidoglycan layerPlasma membrane
02

Mechanism of action

Drugs targeting these structures work by inhibiting the biosynthesis of essential polymers like peptidoglycan or beta-glucans, or by directly disrupting the physical integrity of the lipid bilayer to cause cytoplasmic leakage (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Structural integrityOsmotic regulationSelective permeabilityCell divisionEnvironmental sensing
04

Disease associations

Bacterial infectionFungal infectionSepsisAntimicrobial resistance
05

Safety considerations

NephrotoxicityOtotoxicityHypersensitivity reactionsJarisch-Herxheimer reactionDevelopment of multi-drug resistance (MDR)
06

Interacting drugs

Penicillin G

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)ProcalcitoninC-reactive protein1,3-Beta-D-glucan assay

Beyond the preview

Go deeper on Microbial cell wall and cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell wall and cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call